Incyte (INCY) Misses Q1 EPS by 18c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $122.85 +4.47%
Financial Fact:
Total costs and expenses: 247.18M
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Total costs and expenses: 247.18M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q1 EPS of $0.64, $0.18 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $880.89 million versus the consensus estimate of $925 million.
GUIDANCE:
Incyte sees FY2024 revenue of $2.69-2.75 billion, versus the consensus of $4.12 billion.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Progyny (PGNY) Tops Q3 EPS by 21c ; Offers Guidance
- Innoviva (INVA) Misses Q3 EPS by 156c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
